Biofil Chemicals and Pharmaceuticals Limited (BOM:524396)

India flag India · Delayed Price · Currency is INR
30.31
-1.19 (-3.78%)
At close: Mar 9, 2026
-34.73%
Market Cap 493.42M
Revenue (ttm) 322.66M
Net Income (ttm) 27.73M
Shares Out 16.27M
EPS (ttm) 1.70
PE Ratio 17.83
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 683
Average Volume 4,077
Open 30.70
Previous Close 31.50
Day's Range 29.60 - 32.37
52-Week Range 28.01 - 56.36
Beta 0.13
RSI 40.93
Earnings Date Feb 13, 2026

About BOM:524396

Biofil Chemicals and Pharmaceuticals Limited engages in manufacturing and trading of pharmaceuticals in India. It operates through Pharmaceutical and Chemical divisions. The company offers basic drugs and chemicals, such as sodium chloride, potassium chloride, sodium citrate, diethyl carbamazine citrate, ferrous sulphate, dried ferrous sulphate, ferrous fumerate, micro crystalline cellulose, and dicyclomine hydrochloride; and packaging solutions. It also provides job work service for manufacturing pharmaceutical drugs. Biofil Chemicals and Phar... [Read more]

Industry Pharmaceutical Preparations
Founded 1985
Employees 26
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524396
Full Company Profile

Financial Performance

In fiscal year 2025, BOM:524396's revenue was 335.82 million, a decrease of -16.89% compared to the previous year's 404.09 million. Earnings were 5.58 million, a decrease of -21.36%.

Financial Statements

News

There is no news available yet.